首页> 外文期刊>BMC Veterinary Research >The effect of bone allografts combined with bone marrow stromal cells on the healing of segmental bone defects in a sheep model
【24h】

The effect of bone allografts combined with bone marrow stromal cells on the healing of segmental bone defects in a sheep model

机译:同种异体骨联合骨髓基质细胞对绵羊模型节段性骨缺损愈合的影响

获取原文
           

摘要

Background The repair of large bone defects is a major orthopedic challenge because autologous bone grafts are not available in large amounts and because harvesting is often associated with donor-site morbidity. Considering that bone marrow stromal cells (BMSC) are responsible for the maintenance of bone turnover throughout life, we investigated bone repair at a site of a critically sized segmental defect in sheep tibia treated with BMSCs loaded onto allografts. The defect was created in the mid-portion of the tibial diaphysis of eight adult sheep, and the sheep were treated with ex-vivo expanded autologous BMSCs isolated from marrow aspirates and loaded onto cortical allografts (n = 4). The treated sheep were compared with control sheep that had been treated with cell-free allografts (n = 4) obtained from donors of the same breed as the receptor sheep. Results The healing response was monitored by radiographs monthly and by computed tomography and histology at six, ten, fourteen, and eighteen weeks after surgery. For the cell-loaded allografts, union was established more rapidly at the interface between the host bone and the allograft, and the healing process was more conspicuous. Remodeling of the allograft was complete at 18?weeks in the cell-treated animals. Histologically, the marrow cavity was reestablished, with intertrabecular spaces being filled with adipose marrow and with evidence of focal hematopoiesis. Conclusions Allografts cellularized with AOCs (allografts of osteoprogenitor cells) can generate great clinical outcomes to noncellularized allografts to consolidate, reshape, structurally and morphologically reconstruct bone and bone marrow in a relatively short period of time. These features make this strategy very attractive for clinical use in orthopedic bioengineering.
机译:背景技术大骨缺损的修复是整形外科的主要挑战,因为自体骨移植物数量不多,而且收获往往与供体部位发病率有关。考虑到骨髓基质细胞(BMSC)负责整个生命周期的骨更新,我们调查了用同种异体移植骨上的BMSC处理的绵羊胫骨中一个临界尺寸节段性缺损部位的骨修复。该缺陷是在八只成年绵羊的胫骨干physi端的中部产生的,并用从骨髓穿刺物中分离出的离体扩增自体骨髓间充质干细胞对绵羊进行了处理,并将其装载到同种异体皮质移植物中(n = 4)。将处理过的绵羊与已经用无细胞同种异体移植物(n = 4)治疗的对照绵羊进行比较,该移植物得自与受体绵羊相同品种的供体。结果术后6、10、14和18周每月进行X光片检查,并通过计算机断层扫描和组织学检查来监测愈合反应。对于细胞负载的同种异体移植,在宿主骨骼和同种异体移植物之间的界面处建立联合的速度更快,并且愈合过程更加明显。在用细胞处理的动物中,同种异体移植的重塑在18周时完成。从组织学上讲,重建了骨髓腔,小梁间间隙充满了脂肪的骨髓,并伴有局灶性造血功能。结论用AOCs细胞化的同种异体移植物(骨祖细胞同种异体移植物)可以在相对较短的时间内对非细胞化同种异体移植物进行巩固,重塑,结构和形态重建的临床结果。这些功能使该策略对于骨科生物工程的临床应用非常有吸引力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号